Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few putative mechanisms include: microbial induction of epithelial μ-opioid and cannabinoid receptors as shown with oral administration of Lactobacillus strains in rodents69”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [69]
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [60]
In the citing paper
“Interestingly, we saw beneficial effects especially on distension and pain, as this agrees well with the recent findings that certain lactobacilli can induce the expression of pain-sensing receptors in intestinal epithelial cells. 33”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [33]
In the citing paper
“In addition, exposure of rats to L. reuteri (83) or L. acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells (151).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [151]
In the citing paper
“Evidence for such mutual interaction has been demonstrated in gut inflammation,14 visceral pain,77 certain symptoms of IBS,12 and in obesity.78”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [77]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409188102 · Cited by 590
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Cervero, F., & Laird, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01306-9 · Cited by 434
Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic
Sanders, M. E., & Klaenhammer, T. R. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74481-5 · Cited by 433
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Cited by
Items 101–200 of 793
Immunomodulation by commensal and probiotic bacteria
Forsythe, P., & Bienenstock, J. (2010) · Immunological Investigations · doi:10.3109/08820131003667978 · Cited by 189
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
“First evidence for the link between specific bacteria and the endocannabinoid system came from a study in which administration of Lactobacillus acidpophilus modulated the expression of cannabinoid receptors in intestinal cells in rats [121].”
BackgroundWasilewski, A., Zielińska, M., Storr, M., & Fichna, J. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000364 · Cited by 185
Irritable bowel syndrome: Emerging paradigm in pathophysiology
Lee, Y. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2456 · Cited by 185
Julio-Pieper, M., Flor, P. J., Dinan, T. G., & Cryan, J. F. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.004036 · Cited by 184
“, 2002), endocrine system (Turnbaugh and Gordon, 2009), and pain processing (Rousseaux et al., 2007; O’Mahony et al., 2010) and in behavioral changes (Forsythe et al.”
BackgroundGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Infant colic: mechanisms and management
Zeevenhooven, J., Browne, P. D., L’Hoir, M. P., de Weerth, C., & Benninga, M. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0008-7 · Cited by 168
Gastrointestinal hormones and the dialogue between gut and brain
Dockray, G. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.270850 · Cited by 184
Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179
Mao, Y.-K., Kasper, D. L., Wang, B., Forsythe, P., Bienenstock, J., & Kunze, W. A. (2013) · Nature Communications · doi:10.1038/ncomms2478 · Cited by 178
Ringel-Kulka, T., Palsson, O. S., Maier, D., Carroll, I., Galanko, J. A., Leyer, G., & Ringel, Y. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31820ca4d6 · Cited by 174
Self-citationProbiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
Dale, H. F., Rasmussen, S. H., Asiller, Ö. Ö., & Lied, G. A. (2019) · Nutrients · doi:10.3390/nu11092048 · Cited by 166
“Studies in both animals and humans have suggested that different strains of probiotics may improve abdominal pain and reduce visceral hypersensitivity by modulation of expression of neurotransmitters and receptors involved in the modulation of pain, such as the opioid receptor or the cannabinoid receptor [22,23].”
Parkes, G. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01869.x · Cited by 167
“to upregulate μ-opioid and cannaboid receptors in colonic epithelial cell lines and in the colonic epithelium in pretreated rats and mice (77).”
BackgroundMoloney, R. D., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00015 · Cited by 161
Luminal hydrogen sulfide plays a pronociceptive role in mouse colon
Matsunami, M., Tarui, T., Mitani, K., Nagasawa, K., Fukushima, O., Okubo, K., Yoshida, S., Takemura, M., & Kawabata, A. (2009) · Gut · doi:10.1136/gut.2007.144543 · Cited by 167
Bacterial Signaling to the Nervous System through Toxins and Metabolites
Yang, N. J., & Chiu, I. M. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.023 · Cited by 165
The gut Microbiome in adult and pediatric functional gastrointestinal disorders
Shin, A., Preidis, G. A., Shulman, R., & Kashyap, P. C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.054 · Cited by 163
Aguilera, M., Cerdà-Cuéllar, M., & Martínez, V (2015) · Gut Microbes · doi:10.4161/19490976.2014.990790 · Cited by 162
“Similarly to that observed here, during spontaneous adaptive changes of the microbiota or during the administration of probiotics, both the endocannabinoid and opioid systems were modulated.(19,21,42,43) However, the changes observed contrast with those after short (1-week) treatment with the same antibiotic regime, i…”
BackgroundResultThe gut microbiome and mental health: implications for anxiety- and trauma-related disorders
Malan-Muller, S., Valles-Colomer, M., Raes, J., Lowry, C. A., Seedat, S., & Hemmings, S. M. J. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2017.0077 · Cited by 161
“In addition, they illustrated that deficiency of IEC miRNAs increases the dissimilarity of the gut microbiota and alters intestinal barrier integrity.”
InfluentialMcPartland, J. M., Guy, G. W., & Di Marzo, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089566 · Cited by 161
“The antinociceptive effects of EA were attenuated by the CB2 antagonist AM630, but not by the CB1 antagonist AM251 [222].”
BackgroundInfluentialZhang, L., Meng, J., Ban, Y., Jalodia, R., Chupikova, I., Fernandez, I., Brito, N., Sharma, U., Abreu, M. T., Ramakrishnan, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901182116 · Cited by 162
“A recent report showed an increase in OPRM1 expression in human HT-29 epithelial cells following treatment with Lactobacillus (especially Lactobacillus acidophilus NCFM) (36).”
BackgroundImpact of dietary fats on brain functions
Chianese, R., Coccurello, R., Viggiano, A., Scafuro, M., Fiore, M., Coppola, G., Operto, F. F., Fasano, S., Laye, S., Pierantoni, R., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171017102547 · Cited by 159
“The oral administration of the probiotic Lactobacillus acidophilus demonstrated to induce the expression of CB2 receptors in intestinal epithelial cells [94], providing a seminal evidence for the existence of a communication system between microbiota, probiotics and modulation of the eCB function.”
BackgroundImpact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 171
“The ability of probiotics to activate specific opioid and cannabinoid receptors in the gut makes them useful to reduce visceral pain in patients with IBS and chronic IBD [352].”
BackgroundThe microbiota-gut-brain axis in functional gastrointestinal disorders
De Palma, G., Collins, S. M., & Bercik, P. (2014) · Gut Microbes · doi:10.4161/gmic.29417 · Cited by 157
WILLIAMS, E. A., STIMPSON, J., WANG, D., PLUMMER, S., GARAIOVA, I., BARKER, M. E., & CORFE, B. M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03848.x · Cited by 156
Everard, A., Plovier, H., Rastelli, M., Hul, M. V., d’Oplinter, A. D. W., Geurts, L., Druart, C., Robine, S., Delzenne, N. M., Muccioli, G. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08051-7 · Cited by 165
Cannabinoids, endocannabinoids, and cancer
Hermanson, D. J., & Marnett, L. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9318-8 · Cited by 177
“oral administration of specific Lactobacillus strains induces CB2 receptor expression in colonic epithelial cells through the NF–κB pathway [37].”
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Forsythe, P., Kunze, W., & Bienenstock, J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0604-8 · Cited by 156
“Several investigators have shown that ingestion of specific microbes can reduce or inhibit visceral pain induced by gut distension in rodents [33–35]).”
The effect of gut microbiome on tolerance to morphine mediated antinociception in mice
Kang, M., Mischel, R. A., Bhave, S., Komla, E., Cho, A., Huang, C., Dewey, W. L., & Akbarali, H. I. (2017) · Scientific Reports · doi:10.1038/srep42658 · Cited by 154
Pathophysiological role of host microbiota in the development of obesity
Kobyliak, N., Virchenko, O., & Falalyeyeva, T. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0166-9 · Cited by 149
“At the same time, another group found that administration of Lactobacillus acidophilus increases CB2 receptor expression in the colon in mice [94].”
ResultDrouault-Holowacz, S., Bieuvelet, S., Burckel, A., Cazaubiel, M., Dray, X., & Marteau, P. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2007.06.001 · Cited by 151
A Gastroenterologist's Guide to Probiotics
Ciorba, M. A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.03.024 · Cited by 150
Probiotics and prebiotics – Progress and challenges
Reid, G. (2008) · International Dairy Journal · doi:10.1016/j.idairyj.2007.11.025 · Cited by 170
“…of L. acidophilus NCFM, an organism used extensively in the USA as a ‘probiotic’ in dairy products, induced the expression of m-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut – similar to the effects of morphine (Rousseaux et al., 2007).”
BackgroundSisson, G., Ayis, S., Sherwood, R. A., & Bjarnason, I. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12787 · Cited by 147
Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?
Hughes, P. A., Zola, H., Penttila, I. A., Blackshaw, A. L., Andrews, J. M., & Krumbiegel, D. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.120 · Cited by 148
Probiotics in the Management of Lung Diseases
Mortaz, E., Adcock, I. M., Folkerts, G., Barnes, P. J., Vos, A. P., & Garssen, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/751068 · Cited by 155
“In addition, they have been proposed to be of potential benefit in increasing numbers of therapeutic areas, particularly in the prevention or treatment of many different chronic inflammatory diseases [5].”
BackgroundAcne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine
Bowe, W., Patel, N. B., & Logan, A. C. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0060 · Cited by 142
“…that regulation of lipid production by sebocytes is under control of the cannabinoid receptor-2 (CB-2), a finding that takes on greater meaning given the preliminary findings concerning the ability of probiotic strains to influence CB-2 expression (Rousseaux et al., 2007; Toth et al., 2011).”
BackgroundResultDuncan, M., Mouihate, A., Mackie, K., Keenan, C. M., Buckley, N. E., Davison, J. S., Patel, K. D., Pittman, Q. J., & Sharkey, K. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90285.2008 · Cited by 144
“In the gut, CB2 receptors are upregulated in submucosal and mucosal infiltrate in experimental models of colitis and in IBD (18; 48) and in the epithelium after treatment with the probiotic Lactobacillus acidophilis in rats and mice (34).”
BackgroundProbiotics as Complementary Treatment for Metabolic Disorders
Le Barz, M., Anhê, F. F., Varin, T. V., Desjardins, Y., Levy, E., Roy, D., Urdaci, M. C., & Marette, A. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.291 · Cited by 142
“, inflammatory mediators, defensins, serotonin, proteases, mucus quality, and the endocannabinoid system) [36].”
Alhouayek, M., & Muccioli, G. G. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.07.009 · Cited by 162
Probiotics, Enteric and Diarrheal Diseases, and Global Health
Preidis, G. A., Hill, C., Guerrant, R. L., Ramakrishna, B. S., Tannock, G. W., & Versalovic, J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.010 · Cited by 138
“[84,85] Lactobacilli can also blunt visceral pain responses by increasing expression of enterocyte opioid and cannabinoid receptors[86] or by inhibiting sodium channels.”
BackgroundDiPatrizio, N. V. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0001 · Cited by 136
Probiotics in the critically ill: A systematic review of the randomized trial evidence
Petrof, E. O., Dhaliwal, R., Manzanares, W., Johnstone, J., Cook, D., & Heyland, D. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260cc33 · Cited by 132
The normal intestinal microbiota
Marchesi, J., & Shanahan, F. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a56a99 · Cited by 134
Maranduba, C. M. D. C., De Castro, S. B. R., Souza, G. T. D., Rossato, C., da Guia, F. C., Valente, M. A. S., Rettore, J. V. P., Maranduba, C. P., Souza, C. M. D., Carmo, A. M. R. D., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/931574 · Cited by 134
“Further studies are still needed in order to clarify the interaction between gut microbiota and neuroimmune system, as well as with endocrine system, so as to create nutrigenetic profiles that may aid in reaching individual homeostasis.”
BackgroundTherapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 157
da Silva, K. A. B. S., Paszcuk, A. F., Passos, G. F., da Silva, E. S., Bento, A. F., Meotti, F. C., & Calixto, J. Β. (2011) · Pain · doi:10.1016/j.pain.2011.04.005 · Cited by 147
“) [48] 30 minutes before a,b-amyrin (30 mg/kg p.”
Vlieg, J. E. V. H., Veiga, P., Zhang, C., Derrien, M., & Zhao, L. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.12.004 · Cited by 147
“In recent years there has been broad array of health modulating metabolites described including anti-inflammatory factors produced by commensals such as Faecalibacterium prausnitzii [53 ] and compounds that can modulate intestinal pain [54].”
BackgroundCannabis Therapeutics and the Future of Neurology
Russo, E. B. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00051 · Cited by 131
Ouwehand, A. C., Invernici, M. M., Furlaneto, F. A. C., & Messora, M. R. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001052 · Cited by 127
Self-citationWageningen Academic Publishers
Uyttendaele, M., Devlieghere, F., & Verhé, R. (2005) · Ghent University Academic Bibliography (Ghent University) · Cited by 129
Cremon, C., Stanghellini, V., Barbaro, M. R., Cogliandro, R. F., Bellacosa, L., Santos, J., Vicario, M., Pigrau, M., Alonso, C., Lobo, B., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13958 · Cited by 136
Ueno, N., Fujiya, M., Segawa, S., Nata, T., Moriichi, K., Tanabe, H., Mizukami, Y., Kobayashi, N., Ito, K., & Kohgo, Y. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21597 · Cited by 128
Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021) · JGH Open · doi:10.1002/jgh3.12528 · Cited by 146
Sun, Y.-Y., Li, M., Li, Y.-Y., Li, L.-X., Zhai, W.-Z., Wang, P., Yang, X.-X., Gu, X., Song, L.-J., Li, Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21241-z · Cited by 126
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859967 · Cited by 125
Exploring the role of gut microbiome in male reproduction
Wang, Y., & Xie, Z. (2021) · Andrology · doi:10.1111/andr.13143 · Cited by 135
Gut Microbiota Are Disease-Modifying Factors After Traumatic Spinal Cord Injury
Kigerl, K. A., Mostacada, K., & Popovich, P. G. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0583-2 · Cited by 135
Perez‐Burgos, A., Wang, L., McVey Neufeld, K., Mao, Y., Ahmadzai, M., Janssen, L. J., Stanisz, A. M., Bienenstock, J., & Kunze, W. A. (2015) · The Journal of Physiology · doi:10.1113/jp270229 · Cited by 123
“…in rodent models to test whether the ingestion of specific potentially beneficial bacteria may reduce visceral pain perception (Kamiya et al. 2006; Rousseaux et al. 2007; Collins et al. 2009; Duncker et al. 2011), and they are commonly used to test whether any molecule or receptor is involved in…”
BackgroundInfluentialMartoni, C. J., Srivastava, S., & Leyer, G. J. (2020) · Nutrients · doi:10.3390/nu12020363 · Cited by 123
“acidophilus has been shown to normalize visceral pain responses via induced expression of opioid and cannabinoid receptors in the gut [45].”
BackgroundSelf-citationIntestinal Microbiota and its Role in Irritable Bowel Syndrome (IBS)
Öhman, L., & Simrén, M. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0323-7 · Cited by 138
“paracasei have been reported to modulate pain and visceral hypersensitivity perception, respectively [53, 54].”
BackgroundAlteration in Taste Perception in Cancer: Causes and Strategies of Treatment
Murtaza, B., Hichami, A., Khan, A. S., Ghiringhelli, F., & Khan, N. A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00134 · Cited by 134
“One possible mechanism might be that the modifications of gut microbiota might influence the expression of gut G-protein coupled receptors (Rousseaux et al., 2007), beside manipulating host feeding behavior through hormonal and neural mechanisms (Alcock et al., 2014).”
BackgroundBeyond Cannabis: Plants and the Endocannabinoid System
Russo, E. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.005 · Cited by 152
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease
Hasenoehrl, C., Taschler, U., Storr, M., & Schicho, R. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12931 · Cited by 119
Aguilera, M., Vergara, P., & Martínez, V. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12154 · Cited by 119
Pineton de Chambrun, G., Neut, C., Chau, A., Cazaubiel, M., Pelerin, F., Justen, P., & Desreumaux, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.007 · Cited by 120
Self-citationLactobacilli as multifaceted probiotics with poorly disclosed molecular mechanisms
Turpin, W., Humblot, C., Thomas, M., & Guyot, J. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.07.032 · Cited by 141
“acidophilus NCFM was increased by 20% compared to untreated rat and this effect was dose dependent (Rousseaux et al., 2007).”
BackgroundJang, H.-M., Lee, K.-E., Lee, H.-J., & Kim, D.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-31764-0 · Cited by 116
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
“acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of -opioid and cannabinoid receptors in intestinal epithelial cells (151).”
BackgroundZheng, X., Lyu, L., & Mei, Z. (2013) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082013000800002 · Cited by 113
“Iopioid and cannabinoid receptors can also be activated by probiotics, thus the discomfort resulting from antibiotics relieves (43).”
Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence
Lai, N. Y., Mills, K., & Chiu, I. M. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12591 · Cited by 114
Kabouridis, P. S., & Pachnis, V. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76308 · Cited by 126
“Similarly, Lactobacillus acidophilus administration had an analgesic effect in a model of colonic hypersensitivity by inducing the expression of opioid and cannabinoid receptors (121).”
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
JASIRWAN, C. O. M., LESMANA, C. R. A., HASAN, I., SULAIMAN, A. S., & GANI, R. A. (2019) · Bioscience of Microbiota, Food and Health · doi:10.12938/bmfh.18-032 · Cited by 106
“, in which the administration of a Lactobacillus acidophilus strain modulated CB receptors expression in the intestinal cells of rats [47].”
BackgroundCan we ‘seize’ the gut microbiota to treat epilepsy?
De Caro, C., Iannone, L. F., Citraro, R., Striano, P., De Sarro, G., Constanti, A., Cryan, J. F., & Russo, E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.002 · Cited by 110
Lin, R., Sun, Y., Mu, P., Zheng, T., Mu, H., Deng, F., Deng, Y., & Wen, J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113868 · Cited by 115
Distrutti, E., Cipriani, S., Mencarelli, A., Renga, B., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063893 · Cited by 107
“Oligo Name Sense Antisense rCCL2 atgcagttaatgccccactc ttccttattggggtcagcac rNOS3 caatcttcgttcagccatca gggtccagccatgttgaata rNTRK1 gtctggtgggtcagggacta cacacatcactctcggtgct rTPH1 gacatctttcccctgctgaa tctttgaagccaggatggtc rCCR2 ctgcccctacttgtcatggt ggcctggtctaagtgcatgt rBDKRB1 ccccgtgactgctatcatct agaccaggaaggaggctacc r…”
InfluentialIrritable bowel syndrome symptom severity improves equally with probiotic and placebo
Lyra, A., Hillilä, M., Huttunen, T., Männikkö, S., Taalikka, M., Tennilä, J., Tarpila, A., Lahtinen, S., Ouwehand, A. C., & Veijola, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10631 · Cited by 106
Self-citationIntestinal microbiota in pathophysiology and management of irritable bowel syndrome.
(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106
Microflora Modulation of Motility
Quigley, E. M. M. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.2.140 · Cited by 106
Onal, E. M., Afşar, B., Covic, A. C., Vaziri, N. D., & Kanbay, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0144-z · Cited by 121
Maia, J. C., FONSECA, B. K. S., Teixeira, N. A. A., & Correia‐da‐Silva, G. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa005 · Cited by 120
“bacillus acidophilus exerts antinociceptive effects against visceral pain through the increase of CB2 expression in the intestinal epithelial cells (Rousseaux et al., 2007).”
BackgroundWang, B., Mao, Y. ‐., Diorio, C., Wang, L., Huizinga, J. D., Bienenstock, J., & Kunze, W. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01384.x · Cited by 107
Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 124
“Other studies on rodents revealed that some bacterial species such as Lactobacillus paraca‐ sei and Lactobacillus acidophilus could induce opioid and cannabinoid receptors in intestinal epithelial cells, which will prevent visceral hypersensitivity and reduce pain perception [281, 293, 294].”
BackgroundZoonotic helminth infections of humans: echinococcosis, cysticercosis and fascioliasis
Garcia, H. H., Moro, P. L., & Schantz, P. M. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a95e39 · Cited by 120
Probiotic Properties of Lactobacillus Salivarius and Closely Related Lactobacillus Species
Neville, B., & O‘Toole, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.35 · Cited by 104
Goh, Y. J., & Klaenhammer, T. R. (2014) · Microbial Cell Factories · doi:10.1186/s12934-014-0094-3 · Cited by 103
“[27] and the alleviation of abdominal pain via modulation of visceral pain perception [28].”
BackgroundCannabinoids in intestinal inflammation and cancer
Izzo, A. A., & Camilleri, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.008 · Cited by 112
Visceral pain: gut microbiota, a new hope?
Pusceddu, M. M., & Gareau, M. G. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0476-7 · Cited by 101
Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
Ouwehand, A. C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., & Miller, L. E. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.053 · Cited by 98
Self-citationThe gut microbiota as a key regulator of visceral pain
O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2016) · Pain · doi:10.1097/j.pain.0000000000000779 · Cited by 108
Wang, B., Mao, Y., Diorio, C. J., Pasyk, M., Wu, R., Bienenstock, J., & Kunze, W. (2010) · The FASEB Journal · doi:10.1096/fj.09-153841 · Cited by 107
“reuteri could potentially act on intestinal mucosal epithelial cells (3, 20) and/or cells of the immune system (3, 4, 89).”
BackgroundMaayah, Z. H., Takahara, S., Ferdaoussi, M., & Dyck, J. R. B. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165771 · Cited by 111
Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations
Lamichhane, S., Sen, P., Alves, M. A., Ribeiro, H. C., Raunioniemi, P., Hyötyläinen, T., & Orešič, M. (2021) · Metabolites · doi:10.3390/metabo11010055 · Cited by 107
KAJANDER, K., KROGIUS‐KURIKKA, L., RINTTILÄ, T., KARJALAINEN, H., PALVA, A., & KORPELA, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03391.x · Cited by 95
Deng, L., Guindon, J., Vemuri, V. K., Thakur, G. A., White, F. A., Makriyannis, A., & Hohmann, A. G. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-71 · Cited by 94
“) [71] or CB1 antagonist AM251 (3 mg/kg i.”
Miyauchi, E., O’Callaghan, J., Buttó, L. F., Hurley, G., Melgar, S., Tanabe, S., Shanahan, F., Nally, K., & O’Toole, P. W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00003.2012 · Cited by 101
“Their beneficial mechanisms include direct antagonism against pathogens such as Listeria monocytogenes (7), modulation of inflammation in response to pathogens (54), and antinociceptive activity (52).”
BackgroundIncretins in obesity and diabetes
Chia, C. W., & Egan, J. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14211 · Cited by 93
Vijay, A., Kouraki, A., Gohir, S., Turnbull, J., Kelly, A., Chapman, V., Barrett, D. A., Bulsiewicz, W. J., & Valdes, A. M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1997559 · Cited by 93
“has been known that specific gut microbial strains modulate the expression of cannabinoid and μopioid receptors in intestinal cells.(19) Extensive work in animal models has shown that gut microbes also counteract obesity-induced overactivity of the EC system in the mouse colon, with subsequent reduction of gut permeab…”
BackgroundMa, X., Mao, Y.-K., Wang, B., Huizinga, J. D., Bienenstock, J., & Kunze, W. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90511.2008 · Cited by 93
“Experimental modulation of intestinal motility (32) and visceral pain (18, 32, 43) by Lactobacillus species have been convincingly demonstrated for the murine colon.”
BackgroundResultBrun, P., Gobbo, S., Caputi, V., Spagnol, L., Schirato, G., Pasqualin, M., Levorato, E., Palù, G., Giron, M. C., & Castagliuolo, I. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.018 · Cited by 92
“Recent research papers further strengthened the relationship between gut microbiota and the ENS revealing that the gut microbes directly modify colonic neuropeptide content and receptor distribution (Nasser et al., 2007; Rousseaux et al., 2007).”
Metadata
- Authors
- Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.-F., Ardid, D., & Desreumaux, P.
- Affiliations
- Inserm (FR)
- Université Clermont Auvergne (FR)
- KU Leuven (BE)
- Corresponding author
- Desreumaux, Pierre
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-12-10
- Volume
- 13
- Issue
- 1
- Pages
- 35-37
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1966470298
- Cited by
- 793
- References
- 16
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 38 · 2023: 46 · 2022: 44 · 2021: 48 · 2020: 42 · 2019: 50 · 2018: 53 · 2017: 40 · 2016: 42 · 2015: 34 · 2014: 47 · 2013: 58 · 2012: 44
- FWCI
- 26.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Lactobacillus acidophilus, intestinal pain, abdominal pain, irritable bowel syndrome, visceral hypersensitivity, mu-opioid receptor, cannabinoid receptors, intestinal epithelial cells, gut microbiota, analgesia, probiotics
- MeSH terms
- Administration, Oral, Analgesics, Opioid, Animals, Colon, Dose-Response Relationship, Drug, Humans, Indoles, Intestines, Lactobacillus acidophilus, Male, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Receptors, Opioid, Rectum, Abdominal Pain, Rats, Sprague-Dawley, Receptors, Opioid, mu, HT29 Cells, Probiotics, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.